Eisai Co. Ltd.'s Fiscal Year is From April To March.
The item "Price-To-Sales-Ratio" stands at 1.73 as of 09/30/2025.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Price To Sales Ratio" stands at 1.73. This represents an increase of 24.89 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -16.23 percent compared to the value the year prior.
The 1 year change in percent is -16.23.
The 3 year change in percent is -34.57.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price To Sales Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Price To Sales Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Price To Sales Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Price To Sales Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Price To Sales Ratio | 280,205,508,085.11 |